MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-14-2026
Co-Diagnostics P/S Ratio 2011-2026 | CODX
Annual P/S Ratio Co-Diagnostics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.4 | 1.14 | 5.13 | 2.73 | 2.63 | 4.84 | 210 | 701 | 4.19 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.19 K | 1.14 | 570 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
6.64 | $ 115.84 | 0.68 % | $ 35.2 B | USA |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
1.37 | $ 21.26 | 7.97 % | $ 616 M | USA |
 |
Aspira Women's Health
AWH
|
0.37 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
0.316 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
1.63 | $ 17.9 | 1.3 % | $ 551 M | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
13.7 | $ 127.51 | 6.39 % | $ 16 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
2.61 | $ 22.16 | 2.88 % | $ 1.18 B | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
Interpace Biosciences
IDXG
|
0.19 | $ 1.8 | - | $ 7.96 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
2 | $ 118.45 | 4.04 % | $ 9.77 B |  Irlanda |
 |
Illumina
ILMN
|
3.75 | $ 150.17 | 3.41 % | $ 23.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
0.244 | - | - | $ 399 M |  China |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 99.09 | -0.97 % | $ 6.69 B | USA |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
19.5 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
7.06 | $ 1 093.84 | -0.68 % | $ 22.5 B |  Schweiz |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 164.49 | 4.95 % | $ 8.15 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
NeoGenomics
NEO
|
2.04 | $ 9.57 | 3.24 % | $ 1.23 B | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 428.0 | -0.26 % | $ 12.3 B | USA |
 |
National Research Corporation
NRC
|
2.29 | $ 19.13 | 0.47 % | $ 428 M | USA |
 |
Natera
NTRA
|
6.47 | $ 203.11 | 1.1 % | $ 20 B | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
0.496 | $ 3.94 | 2.34 % | $ 365 M | USA |
 |
Personalis
PSNL
|
6.19 | $ 9.49 | 6.15 % | $ 847 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.7 | $ 26.6 | -1.26 % | $ 25.2 B |  Niderland |
 |
Senseonics Holdings
SENS
|
9.94 | $ 6.32 | -1.71 % | $ 264 M | USA |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
10.9 | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
4.15 | $ 64.17 | -1.08 % | $ 3.84 B | USA |
 |
Biomerica
BMRA
|
1.35 | $ 2.46 | -0.61 % | $ 5.65 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 258.25 | -0.08 % | $ 21.5 B | USA |
 |
Thermo Fisher Scientific
TMO
|
4.4 | $ 456.21 | 1.79 % | $ 172 B | USA |
 |
Waters Corporation
WAT
|
21.1 | $ 342.18 | 1.05 % | $ 20.4 B | USA |
 |
Trinity Biotech plc
TRIB
|
3.15 | $ 0.68 | 5.04 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
1.14 | $ 9.2 | 0.66 % | $ 2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 193.99 | 0.58 % | $ 21.5 B | USA |